OTCM
RQHTF
Market cap0kUSD
Oct 01, Last price
0.00USD
Name
Reliq Health Technologies Inc
Chart & performance
P/E
—
P/S
0.00
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
83.36%
Revenues
9m
+484.87%
Net income
-8m
L-30.64%
CFO
-8m
L+12.97%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Reliq Health Technologies Inc. is a health technology firm specializing in the development of secure virtual care and telehealth solutions for the healthcare sector. Its primary offering is the iUGO Care platform, delivered as a Software-as-a-Service (SaaS), which is designed to enable patients with complex conditions to receive medical attention from the comfort of their homes. Established in 2005, the company initially operated as Moseda Technologies Inc. before rebranding to its current name in May 2016. Reliq Health maintains its headquarters in Hamilton, Canada.
Key people
Brian Storseth
Chairman of the Board · since 2016
Bassma Ghali
Chief Technology Officer · since 2018
Lucas Smithen
Vice President - Products and Professional Services · since 2018
Richard Sztramko
Chief Medical Officer · since 2017
Director · since 2015
Lisa Crossley
Chief Executive Officer, Director · since 2016
Aman Thindal
Chief Financial Officer, Director · since 2015
Headquarters & legal address
Suite 810 - 789 West Pender Street
Vancouver, BC V6C 1H2
CA
Vancouver, BC V6C 1H2
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||